Could a blood pressure drug slow Alzheimer's? new trial aims to find out
NCT ID NCT06362707
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This Phase 2 trial tests whether fasudil, a drug already used in Japan and China for brain blood vessel spasms, can improve memory and brain function in people with early Alzheimer's disease. Two hundred participants will receive either fasudil or a placebo for 12 months, with regular cognitive tests and brain scans to measure effects. The goal is to see if fasudil can slow the decline in thinking skills and brain metabolism.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Fasudil (a drug approved in Japan and China for vasospasms, now being tested for Alzheimer's)
- What this could lead to
- If it works, this could point toward a treatment that slows memory loss and brain decline in early Alzheimer's disease.
- What could go wrong
- This is an early Phase 2 trial with only 200 participants, so results may not apply to everyone. The drug is not yet proven for Alzheimer's, and side effects are still being studied.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Akershus Hospital:
NOT_YET_RECRUITINGOslo, Oslo, Norway
-
Haraldsplass Deaconess Hospital
ENROLLING_BY_INVITATIONBergen, Vestland, Norway
-
Haugesund Hospital
NOT_YET_RECRUITINGHaugesund, Rogaland, Norway
-
St. Olavs Hospital:
NOT_YET_RECRUITINGTrondheim, Trøndelag, Norway
-
Stavanger University Hospital
RECRUITINGStavanger, Rogaland, Norway
-
University Hospital of North Norway
NOT_YET_RECRUITINGTromsø, Nordland, Norway
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple questionnaire empower dementia caregivers after hospital stays?
- Could your heart hold the key to Alzheimer's prevention?
- Can a nudge in your chart unlock Life-Saving genetic clues?
- Can a Voice-Based app map healthy brain aging across 80 years?
- Can MRI reveal the Brain's response to deep brain stimulation?
- Can brain scans and gut bacteria reveal Alzheimer's secrets?